BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 18235022)

  • 1. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
    Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
    Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of supplemental erythropoietin on its receptor expression and signal transduction pathways in rat model of retinal detachment.
    Xie Z; Chen F; Wu X; Zhuang C; Zhu J; Wang J; Ji H; Wang Y; Hua X
    Curr Eye Res; 2012 Feb; 37(2):138-44. PubMed ID: 22251399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
    Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
    Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
    Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
    Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-VEGF effects of intravitreal erythropoietin in early diabetic retinopathy.
    Zhang J; Hu LM; Xu G; Wu Y; Shen J; Luo Y; Zhong Y; Sinclair SH; Yanoff M; Li W; Xu GT
    Front Biosci (Elite Ed); 2010 Jun; 2(3):912-27. PubMed ID: 20515763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
    Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
    Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin Protects Retinal Cells in Diabetic Rats Through Upregulating ZnT8 via Activating ERK Pathway and Inhibiting HIF-1α Expression.
    Xu G; Kang D; Zhang C; Lou H; Sun C; Yang Q; Lu L; Xu GT; Zhang J; Wang F
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8166-78. PubMed ID: 26720469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
    Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
    Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
    El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
    Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
    Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
    Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
    Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
    Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.